Renal Denervation Market Size, Share, Trends, Growth Outlook

Renal Denervation Market is estimated to increase at a growth rate of 35.2% CAGR over the forecast period from 2024 to 2030.

The global Renal Denervation Marketstudy analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments including By Product (Symplicity, Enlightn, Vessix, Paradise, Iberis, Others), By Technology (Radiofrequency based, Ultrasound based, Micro-Infusion based), By End-user (Hospitals, Specialty Clinics, Others).

An introduction to Renal Denervation Market in 2024

The renal denervation market is witnessing notable growth in 2024, driven by the increasing prevalence of hypertension, advancements in catheter-based therapies, and the growing adoption of renal denervation procedures for resistant hypertension management and cardiovascular risk reduction. Renal denervation involves the use of catheter-based radiofrequency or ultrasound energy to ablate renal sympathetic nerves, disrupting neural signaling pathways involved in blood pressure regulation, and reducing systemic blood pressure in patients with treatment-resistant hypertension. With innovations in catheter design, energy delivery systems, and procedural techniques, the market is experiencing rapid expansion and adoption of renal denervation technologies, offering patients with uncontrolled hypertension a minimally invasive and effective treatment option to achieve blood pressure control, reduce medication burden, and lower cardiovascular risk factors, improving overall cardiovascular health and outcomes.

Renal Denervation Market Trend: Growing Adoption of Minimally Invasive Renal Denervation Procedures

A prominent trend in the Renal Denervation Market is the increasing adoption of minimally invasive procedures for treating resistant hypertension and other related conditions. Minimally invasive renal denervation techniques, such as catheter-based procedures using radiofrequency or ultrasound energy, offer advantages such as reduced procedure time, shorter hospital stays, and quicker recovery periods compared to traditional surgical approaches. This trend is driven by the growing preference for less invasive treatment options among patients and healthcare providers, coupled with advancements in medical technology and techniques that enable safer and more effective renal denervation procedures.

Renal Denervation Market Driver: Rising Prevalence of Hypertension and Resistant Hypertension

The primary driver of the Renal Denervation Market is the escalating prevalence of hypertension and resistant hypertension worldwide. Hypertension, characterized by elevated blood pressure levels, is a major risk factor for cardiovascular diseases, stroke, and renal failure. Despite the availability of antihypertensive medications, a significant proportion of patients, estimated to be around 10-20%, remain uncontrolled or resistant to treatment, leading to the emergence of resistant hypertension as a significant healthcare challenge. Renal denervation procedures offer a promising therapeutic option for these patients by disrupting sympathetic nerve activity in the renal arteries, thereby lowering blood pressure levels and improving cardiovascular outcomes.

Renal Denervation Market Opportunity: Expansion into Emerging Markets and Indications

An opportunity within the Renal Denervation Market lies in the expansion into emerging markets and indications beyond hypertension. While renal denervation initially gained traction as a treatment for resistant hypertension, there is growing interest in exploring its potential applications in other cardiovascular and renal conditions, such as heart failure, atrial fibrillation, and chronic kidney disease. Additionally, there is untapped potential in emerging markets where the prevalence of hypertension and related disorders is on the rise, and there is a growing need for innovative treatment solutions. By expanding their geographic presence and exploring new therapeutic indications, companies operating in the renal denervation market can capitalize on untapped opportunities for growth and market expansion.

Renal Denervation Market Market Segmentation

By Product
Symplicity
Enlightn
Vessix
Paradise
Iberis
Others
By Technology
Radiofrequency based
Ultrasound based
Micro-Infusion based
By End-User
Hospitals
Specialty Clinics
Others

Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)

Renal Denervation Market Companies

Abbott Laboratories
Ablative Solutions Inc
Boston Scientific Corp
Medtronic PLC
Mercator MedSystems
Otsuka Holdings Co. Ltd
Recor Medical Inc
SoniVie
Symple Surgical
Terumo Corp

Reasons to Buy the Renal Denervation Market Study

• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Renal Denervation Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Renal Denervation Market industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.

TABLE OF CONTENTS

1 Introduction to 2024 Renal Denervation Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Analyzed
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain

2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations

3 Executive Summary
3.1 Global Renal Denervation Market Size Outlook, $ Million, 2021 to 2030
3.2 Renal Denervation Market Outlook by Type, $ Million, 2021 to 2030
3.3 Renal Denervation Market Outlook by Product, $ Million, 2021 to 2030
3.4 Renal Denervation Market Outlook by Application, $ Million, 2021 to 2030
3.5 Renal Denervation Market Outlook by Key Countries, $ Million, 2021 to 2030

4 Market Dynamics
4.1 Key Driving Forces of Renal Denervation Industry
4.2 Key Market Trends in Renal Denervation Industry
4.3 Potential Opportunities in Renal Denervation Industry
4.4 Key Challenges in Renal Denervation Industry

5 Market Factor Analysis
5.1 Value Chain Analysis
5.2 Competitive Landscape
5.2.1 Global Renal Denervation Market Share by Company (%), 2023
5.2.2 Product Offerings by Company
5.3 Porter’s Five Forces Analysis
5.4 Pricing Analysis and Outlook

6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts

7 Global Renal Denervation Market Outlook by Segments
7.1 Renal Denervation Market Outlook by Segments, $ Million, 2021- 2030
By Product
Symplicity
Enlightn
Vessix
Paradise
Iberis
Others
By Technology
Radiofrequency based
Ultrasound based
Micro-Infusion based
By End-User
Hospitals
Specialty Clinics
Others

8 North America Renal Denervation Market Analysis and Outlook To 2030
8.1 Introduction to North America Renal Denervation Markets in 2024
8.2 North America Renal Denervation Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Renal Denervation Market size Outlook by Segments, 2021-2030
By Product
Symplicity
Enlightn
Vessix
Paradise
Iberis
Others
By Technology
Radiofrequency based
Ultrasound based
Micro-Infusion based
By End-User
Hospitals
Specialty Clinics
Others

9 Europe Renal Denervation Market Analysis and Outlook To 2030
9.1 Introduction to Europe Renal Denervation Markets in 2024
9.2 Europe Renal Denervation Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Renal Denervation Market Size Outlook by Segments, 2021-2030
By Product
Symplicity
Enlightn
Vessix
Paradise
Iberis
Others
By Technology
Radiofrequency based
Ultrasound based
Micro-Infusion based
By End-User
Hospitals
Specialty Clinics
Others

10 Asia Pacific Renal Denervation Market Analysis and Outlook To 2030
10.1 Introduction to Asia Pacific Renal Denervation Markets in 2024
10.2 Asia Pacific Renal Denervation Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Renal Denervation Market size Outlook by Segments, 2021-2030
By Product
Symplicity
Enlightn
Vessix
Paradise
Iberis
Others
By Technology
Radiofrequency based
Ultrasound based
Micro-Infusion based
By End-User
Hospitals
Specialty Clinics
Others

11 South America Renal Denervation Market Analysis and Outlook To 2030
11.1 Introduction to South America Renal Denervation Markets in 2024
11.2 South America Renal Denervation Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Renal Denervation Market size Outlook by Segments, 2021-2030
By Product
Symplicity
Enlightn
Vessix
Paradise
Iberis
Others
By Technology
Radiofrequency based
Ultrasound based
Micro-Infusion based
By End-User
Hospitals
Specialty Clinics
Others

12 Middle East and Africa Renal Denervation Market Analysis and Outlook To 2030
12.1 Introduction to Middle East and Africa Renal Denervation Markets in 2024
12.2 Middle East and Africa Renal Denervation Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Renal Denervation Market size Outlook by Segments, 2021-2030
By Product
Symplicity
Enlightn
Vessix
Paradise
Iberis
Others
By Technology
Radiofrequency based
Ultrasound based
Micro-Infusion based
By End-User
Hospitals
Specialty Clinics
Others

13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
Abbott Laboratories
Ablative Solutions Inc
Boston Scientific Corp
Medtronic PLC
Mercator MedSystems
Otsuka Holdings Co. Ltd
Recor Medical Inc
SoniVie
Symple Surgical
Terumo Corp
14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise

By Product
Symplicity
Enlightn
Vessix
Paradise
Iberis
Others
By Technology
Radiofrequency based
Ultrasound based
Micro-Infusion based
By End-User
Hospitals
Specialty Clinics
Others